Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
This study has been completed.
Study NCT00100243 Information provided by PRAECIS Pharmaceuticals Inc.
First Received on December 27, 2004. Last Updated on September 18, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms by Site
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Sponsors listed in this trial
PRAECIS Pharmaceuticals Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers